Expression of p57(kip2) and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

Expression of p57(kip2) and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma.

Expression of p57(kip2) and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34605325

about

Expression of p15INK⁴b and p57KIP² and relationship with clinicopathological features and prognosis in patients with vulvar squamous cell carcinoma.MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.High Skp2/Low p57(Kip2) Expression is Associated with Poor Prognosis in Human Breast Carcinoma.Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.Relevance of immunohistochemical expression of p57kip2 in epithelial ovarian carcinoma- A systematic literature review.Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications The Cdk inhibitor p57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics.

P2860

Q34666213-C9A5BA84-455D-4AF4-AB57-BAB3CA663FC6 Q34784133-5DB147F6-B281-4873-8E1F-BE285F6200F8 Q35918810-EEFE9582-CB92-4194-A5F5-C3D6A4A9F00B Q36378791-776204EB-74D9-425E-B03F-9711CC2489F3 Q36544519-638DC009-0083-497F-943B-FA664EF6FDC0 Q37706763-6E41211D-2442-40A8-861D-001001FD2A57 Q54722141-F228EA9D-E938-4813-8940-9400FC129FB4

P2860

Expression of p57(kip2) and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34605325

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Expression of p57(kip2) and it ...... mary hepatocellular carcinoma.

@ast

Expression of p57(kip2) and it ...... mary hepatocellular carcinoma.

@en

Expression of p57(kip2) and it ...... mary hepatocellular carcinoma.

@nl

type

label

Expression of p57(kip2) and it ...... mary hepatocellular carcinoma.

@ast

Expression of p57(kip2) and it ...... mary hepatocellular carcinoma.

@en

Expression of p57(kip2) and it ...... mary hepatocellular carcinoma.

@nl

prefLabel

Expression of p57(kip2) and it ...... mary hepatocellular carcinoma.

@ast

Expression of p57(kip2) and it ...... mary hepatocellular carcinoma.

@en

Expression of p57(kip2) and it ...... mary hepatocellular carcinoma.

@nl

P1433

Q34605325-3B0E9485-B3B1-464C-8065-241AD33069C7

P1476

Q34605325-DA32F87D-6D0A-4D6D-9CC5-B9E294A4C8B5

P2093

Q34605325-05EA71B4-8CD4-4DBF-B0D0-7342F139E8D6

Q34605325-3DBEC408-65A4-46E2-803A-3D636DB333A7

Q34605325-9D6CFF9E-31FD-4650-AA7E-B42C462F40AD

Q34605325-C213807D-026D-4A1A-B05C-BE3E9FDE87EB

Q34605325-F8C90A8B-B7B7-4AB6-9D90-30541E884E42

P2860

Q34605325-0E1D7B01-55BF-4A0B-AFCC-5C27839CA4CC

Q34605325-2FACCB43-0EF8-4D5C-BFED-13551CA9C4A4

Q34605325-4E26D730-4A38-4CF5-88E1-FEA6F104235A

Q34605325-4EF77878-1176-4AC9-926D-711B3601245D

Q34605325-4FB29EB4-8006-435A-A17B-3A7140611D52

Q34605325-7948DC54-38A8-46D0-ADD9-8C6D6D22C13A

Q34605325-7BCAD753-8725-49E9-B957-8979B7D77F3B

Q34605325-80CC77CA-7B1A-4FF3-B0BC-FED646406E53

Q34605325-822C383D-166B-44B2-8D6C-4AD45E3154F8

Q34605325-8E102678-B8FF-432F-95D1-05BBA2AEA6D6

P304

Q34605325-E68A42E0-C5D0-450F-BEC1-58610BE4B8EC

P31

Q34605325-00F387ED-4E97-409A-A503-558D9BF340AC

P356

Q34605325-E2D56343-215E-4F02-8991-9C4ACE0310DD

P407

Q34605325-39A26F56-0B78-4614-8E93-36F33804AB1C

P433

Q34605325-8FFBDE55-84F5-49C7-86A8-6FCE74B3FD5A

P478

Q34605325-3EA8ADFE-2A3B-4022-91CF-2032A2E39521

P577

Q34605325-5AA83F50-31DA-4CFA-B4E0-42C20BBC3FF3

P5875

Q34605325-C673DB21-3908-4161-B202-4484240760D8

P698

Q34605325-3A718358-6773-421F-9035-7F5DCD01D8C4

P932

Q34605325-22BD0C3E-EBD1-4CA0-915A-120E662F1C77

P356

WJG.V11.I8.1237

P1433

World Journal of Gastroenterology

P1476

Expression of p57(kip2) and it ...... mary hepatocellular carcinoma.

@en

P2093

Hui Guo

http://www.w3.org/2001/XMLSchema#string

Ke-Jun Nan

http://www.w3.org/2001/XMLSchema#string

Shaan-Xi Liu

http://www.w3.org/2001/XMLSchema#string

Zhao Jing

http://www.w3.org/2001/XMLSchema#string

Zhi-Ping Ruan

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of p57/Kip2 protein in normal and neoplastic thyroid tissues

p57Kip2 regulates actin dynamics by binding and translocating LIM-kinase 1 to the nucleus

Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene

Negative regulators of cyclin-dependent kinases and their roles in cancers.

Molecular changes accompanying senescence and immortalization of cultured human mammary epithelial cells.

Expression of p57kip2, Rb protein and PCNA and their relationships with clinicopathology in human pancreatic cancer.

Signal-induced ubiquitination of p57(Kip2) is independent of the C-terminal consensus Cdk phosphorylation site.

Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells.

Immunohistochemical characterization of p57KIP2 expression in human esophageal squamous cell carcinoma.

P304

1237-1240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V11.I8.1237

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7980628

http://www.w3.org/2001/XMLSchema#string

P698

15754413

http://www.w3.org/2001/XMLSchema#string

P932

4250722

http://www.w3.org/2001/XMLSchema#string